Cargando…

Polymeric Nanoparticles Properties and Brain Delivery

Safe and reliable entry to the brain is essential for successful diagnosis and treatment of diseases, but it still poses major challenges. As a result, many therapeutic approaches to treating disorders associated with the central nervous system (CNS) still only show limited success. Nano-sized syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribovski, Laís, Hamelmann, Naomi M., Paulusse, Jos M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705716/
https://www.ncbi.nlm.nih.gov/pubmed/34959326
http://dx.doi.org/10.3390/pharmaceutics13122045
_version_ 1784622015470108672
author Ribovski, Laís
Hamelmann, Naomi M.
Paulusse, Jos M. J.
author_facet Ribovski, Laís
Hamelmann, Naomi M.
Paulusse, Jos M. J.
author_sort Ribovski, Laís
collection PubMed
description Safe and reliable entry to the brain is essential for successful diagnosis and treatment of diseases, but it still poses major challenges. As a result, many therapeutic approaches to treating disorders associated with the central nervous system (CNS) still only show limited success. Nano-sized systems are being explored as drug carriers and show great improvements in the delivery of many therapeutics. The systemic delivery of nanoparticles (NPs) or nanocarriers (NCs) to the brain involves reaching the neurovascular unit (NVU), being transported across the blood–brain barrier, (BBB) and accumulating in the brain. Each of these steps can benefit from specifically controlled properties of NPs. Here, we discuss how brain delivery by NPs can benefit from careful design of the NP properties. Properties such as size, charge, shape, and ligand functionalization are commonly addressed in the literature; however, properties such as ligand density, linker length, avidity, protein corona, and stiffness are insufficiently discussed. This is unfortunate since they present great value against multiple barriers encountered by the NPs before reaching the brain, particularly the BBB. We further highlight important examples utilizing targeting ligands and how functionalization parameters, e.g., ligand density and ligand properties, can affect the success of the nano-based delivery system.
format Online
Article
Text
id pubmed-8705716
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87057162021-12-25 Polymeric Nanoparticles Properties and Brain Delivery Ribovski, Laís Hamelmann, Naomi M. Paulusse, Jos M. J. Pharmaceutics Review Safe and reliable entry to the brain is essential for successful diagnosis and treatment of diseases, but it still poses major challenges. As a result, many therapeutic approaches to treating disorders associated with the central nervous system (CNS) still only show limited success. Nano-sized systems are being explored as drug carriers and show great improvements in the delivery of many therapeutics. The systemic delivery of nanoparticles (NPs) or nanocarriers (NCs) to the brain involves reaching the neurovascular unit (NVU), being transported across the blood–brain barrier, (BBB) and accumulating in the brain. Each of these steps can benefit from specifically controlled properties of NPs. Here, we discuss how brain delivery by NPs can benefit from careful design of the NP properties. Properties such as size, charge, shape, and ligand functionalization are commonly addressed in the literature; however, properties such as ligand density, linker length, avidity, protein corona, and stiffness are insufficiently discussed. This is unfortunate since they present great value against multiple barriers encountered by the NPs before reaching the brain, particularly the BBB. We further highlight important examples utilizing targeting ligands and how functionalization parameters, e.g., ligand density and ligand properties, can affect the success of the nano-based delivery system. MDPI 2021-11-30 /pmc/articles/PMC8705716/ /pubmed/34959326 http://dx.doi.org/10.3390/pharmaceutics13122045 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ribovski, Laís
Hamelmann, Naomi M.
Paulusse, Jos M. J.
Polymeric Nanoparticles Properties and Brain Delivery
title Polymeric Nanoparticles Properties and Brain Delivery
title_full Polymeric Nanoparticles Properties and Brain Delivery
title_fullStr Polymeric Nanoparticles Properties and Brain Delivery
title_full_unstemmed Polymeric Nanoparticles Properties and Brain Delivery
title_short Polymeric Nanoparticles Properties and Brain Delivery
title_sort polymeric nanoparticles properties and brain delivery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705716/
https://www.ncbi.nlm.nih.gov/pubmed/34959326
http://dx.doi.org/10.3390/pharmaceutics13122045
work_keys_str_mv AT ribovskilais polymericnanoparticlespropertiesandbraindelivery
AT hamelmannnaomim polymericnanoparticlespropertiesandbraindelivery
AT paulussejosmj polymericnanoparticlespropertiesandbraindelivery